Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancer.

e17089Background: Ovarian cancer is characterized by frequent mutations at TP53. These tumors also harbor germline mutations at homologous recombination repair (HR) genes, so they rely on DNA-damag...